CIBC Bancorp USA’s Acadia Healthcare ACHC Stock Holding History

CIBC Bancorp USA’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-690,530	Closed	-$16.2M	–	1932
2026 Q1	$16.2M	Buy	+690,530	New	+$12.5M	0.02%	407

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

CCM

Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CIBC Bancorp USA's ACHC Position: Q2 2026 in Review

CIBC Bancorp USA sold out of Acadia Healthcare (ACHC) in Q2 2026, closing a stake of 690,530 shares — an estimated $16.2M sold.

CIBC Bancorp USA first reported a position in ACHC in Q1 2026 and held it in 1 quarter. The position peaked at $16.2M in Q1 2026. 291 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

CIBC Bancorp USA reported no remaining Acadia Healthcare position as of Q2 2026 after selling out during the quarter.
CIBC Bancorp USA sold 690,530 Acadia Healthcare shares in Q2 2026, an estimated $16.2M.
CIBC Bancorp USA first reported a position in Acadia Healthcare in Q1 2026 and held it in 1 quarter.
CIBC Bancorp USA's Acadia Healthcare position peaked at $16.2M in Q1 2026.
291 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.